Pharmaceutical

Cosmo Pharmaceuticals Receives Regulatory Approval by the European Commission for Winlevi(R) in the EU, Following on the Positive CHMP Opinion

Dublin, Ireland--(Newsfile Corp. - October 21, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and...

CleanSpace Acquires TECHspace, Strengthening National Platform and Market Leadership in Life Sciences, Healthcare, and Advanced Technology

PHILADELPHIA, Oct. 20, 2025 /PRNewswire/ -- CleanSpace, a national design-build leader specializing in life sciences, healthcare, advanced manufacturing, and controlled...

HealthVerity and Claritas Rx announce strategic partnership to unlock more actionable real-world insights for commercial, RWE, and HEOR teams

PHILADELPHIA and SOUTH SAN FRANCISCO, Calif., Oct. 20, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and...

A Measles Drug with Strong Activity without Toxicity Can Be Available Now for Emergency Use, Says NanoViricides – NV-387 Broad-Spectrum Antiviral with Activity Against Measles Virus

SHELTON, CT / ACCESS Newswire / October 20, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"),...

HLTH 2025: 150 Past Attendees and Investors Identify Their Five AI Platform Categories Set to Displace Legacy Health IT in 2026

Compiled by Black Book Research from VC PE and banking investors, the briefing ranks which AI-driven categories are converting pilots...

ADARx Pharmaceuticals Announces Clinical Data Presentation at the American Society of Nephrology (ASN) Kidney Week 2025

SAN DIEGO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA...

error: Content is protected !!